Gem Aromatics Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ptigpiatthnsl22h6t80c5cd.pdf

Key Takeaways


Dahej & Krystal: The Investment Cycle

Yash Parekh: "The Dahej facility has been designed as a flexible multipurpose manufacturing platform, enabling rapid product transitions, faster commercialization cycles, and improved asset utilization across multiple chemistries."

Demand & Revenue Headwinds

Suraj Shah: "The clarity has emerged, people have understood that to be the new normal, and they've adjusted their blend requirements. So we see like green shoots in demand coming from there."

Cooling Agents: The Next Growth Leg


US Tariff Mitigation: The US-Plus-One Strategy

Yash Parekh: "There is significant amount of due diligence that is required on any US plus one strategy where the value addition criteria need to be met, as well as the production facilities need to be of a certain standard."

Financial Trajectory & Capital Allocation

Suraj Shah: "I think the goal is to have all products come in, come online by like Q1 of next year. And then we observe our execution and we expect like 50%-60% by next year, by next year end."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue targetINR1,050–1,100 crFY28
EBITDA margin target16–18%FY28
Krystal cash breakevenAt ~45% capacity utilizationFY27
All products online at DahejFull product suite operationalQ1 FY27
Dahej utilization50–60%FY27 end
Dahej peak revenueINR750–800 crFY29 (2–3 years)
Phenol derivatives trial productionAnisole, MEHQ, GuaiacolQ1 FY27
Cooling agent follow-up auditsCompletion with large customersMarch–April 2026
Catalyst preparation for phenol derivativesCompletionEnd of Q4 FY26

Key Metrics

MetricQ3 FY26
Consolidated revenue₹78.9 cr
Standalone revenue₹83.9 cr
Consolidated gross margin23%, improved from 14%
Standalone gross margin18.4%
Consolidated EBITDA margin8.9%, improved from 3%
Standalone EBITDA margin9.1%
Consolidated net loss₹5 cr
Standalone net profit₹4.2 cr, PAT margin 5%
9M FY26 consolidated revenue₹256.1 cr
9M FY26 consolidated EBITDA margin9.7%
9M FY26 consolidated net profit₹0.4 cr, PAT margin 0.2%
FY28 revenue target₹1,050 cr to ₹1,100 cr
FY28 EBITDA margin target16% to 18%
Dahej facility capex incurred~₹250 cr of ~₹270 cr total, largely capitalized
Dahej commercial production start11 December 2025, operations restricted to ~20 days in Q3
Dahej peak revenue potential₹750 cr to ₹800 cr by FY29, based on 3x asset turn on current capacity
Dahej capacity utilization expectation45%–50% by end of FY27, cash breakeven at ~45% utilization
Total capacity post-Dahej~16,000 MTPA, effective 3x expansion
FY25 US export share~60% of total exports